No. | Reference | Maternal age (years) | Gestation (weeks) | Associated disease | Treatment | Maternal outcome | Fetal outcome | 1 | Nakabayashi et al., 1999[8] | 30 | 21 | Preeclampsia | Antithrombin | survive | survive | 2 | Chmait et al., 2000[9] | 24 | 29 | Necrotizing lymphadenitis, EBV | Ampicillin, acyclovir Betamethasone, IgG | death | survive | 3 | Hanaoka et al., 2007[10] | 33 | 21 | B-cell lymphoma | Emergent caesarean section ; R-CHOP chemotherapy | survive | survive | 4 | Teng et al., 2009[11] | 28 | 23 | Autoimmune haemolytic anaemia | No response to corticosteroid; caesarean section | survive | death | 5 | Arewa et al., 2011[12] | 31 | 21 | HIV | HAART | survive | survive | 6 | Shukla et al., 2013[13] | 23 | 10 | NS | No response to prednisolone; spontaneous abortion | survive | death | 7 | Goulding et al., 2014[14] | 27 | 23 | HSV-2 | Acyclovir | survive | death | 8 | Mayama et al., 2014[15] | 28 | 20 | Parvovirus B19 | Prednisolone | survive | survive | 9 | Klein et al., 2014[16] | 39 | 30 | EBV | Corticosteroid, cyclosporine A, etoposide, Rituximab | death | survive | 10 | Tumian et al., 2015[17] | 35 | 38 | CMV | Dexamethasone | death | survive | 11 | Giard et al., 2016[18] | 35 | 13 | Streptococcal pharyngitis, KF lymphadenitis | No response to corticosteroids; dexamethasone and etoposide; abortion | death | death | 12 | Rousselin et al., 2017[19] | 44 | 30 | Raynaud syndrome, thrombocytopenia | Antimicrobial therapy, glucocorticosteroids | survive | survive | 13 | He et al., 2017[20] | 27 | 30 | NK/T cells lymphoma | Dexamethasone, rituximab and etoposide | death | survive | 14 | Ikeda et al., 2017[21] | 36 | 11 | EBV | Dexamethasone, cyclosporine, Etoposide | survive | survive | 15 | Yildiz et al., 2018[22] | 36 | NS | Acute hepatitis, HIV | Metronidazole, ceftriaxone, methylprednisolone, antibiotherapy | survive | survive | 16 | Wang et al., 2018[23] | 40 | NS | UNC13D gene mutation | Etoposide, dexamethasone | survive | death | 17 | Nasser et al., 2018[7] | 36 | 31 | HSV-2 | Acyclovir | survive | death | 18 | Neistadt et al., 2018[24] | NS | 27 | NK/T-cell lymphoma | Corticosteroids, etoposide, pembrolizumab | death | death | 19 | Parrott et al., 2019[25] | 28 | 18 | Lupus | No response to etoposide and corticosteroid | death | death |
|